{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:20Z","timestamp":1740108320506,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00228-023-03566-5","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:02:37Z","timestamp":1695106957000},"page":"1549-1556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Area under the curve of tacrolimus using microsampling devices: towards precision medicine in solid organ transplantation?"],"prefix":"10.1007","volume":"79","author":[{"given":"Aur\u00e9lien","family":"Couette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Tron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9onard","family":"Golbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Franck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Houssel-Debry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Frouget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pascale","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Brenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Rayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Cl\u00e9mence","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Chemouny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-3629","authenticated-orcid":false,"given":"Florian","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"s1","key":"3566_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ajt.12019","volume":"13","author":"AJ Matas","year":"2013","unstructured":"Matas AJ et al (2013) OPTN\/SRTR 2011 annual data report: kidney. Am J Transplant 13(s1):11\u201346. https:\/\/doi.org\/10.1111\/ajt.12019","journal-title":"Am J Transplant"},{"issue":"2","key":"3566_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","volume":"31","author":"P Wallemacq","year":"2009","unstructured":"Wallemacq P et al (2009) Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European Consensus Conference. Ther Drug Monit 31(2):139\u2013152. https:\/\/doi.org\/10.1097\/FTD.0b013e318198d092","journal-title":"Ther Drug Monit"},{"issue":"3","key":"3566_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00007691-200206000-00004","volume":"24","author":"VC McAlister","year":"2002","unstructured":"McAlister VC, Mahalati K, Peltekian KM, Fraser A, MacDonald AS (2002) A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration. Ther Drug Monit 24(3):346\u2013350. https:\/\/doi.org\/10.1097\/00007691-200206000-00004","journal-title":"Ther Drug Monit"},{"issue":"3","key":"3566_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M et al (2019) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit 41(3):261\u2013307. https:\/\/doi.org\/10.1097\/FTD.0000000000000640","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3566_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4155\/bio.14.310","volume":"7","author":"N Spooner","year":"2015","unstructured":"Spooner N et al (2015) A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. Bioanalysis 7(6):653\u2013659. https:\/\/doi.org\/10.4155\/bio.14.310","journal-title":"Bioanalysis"},{"key":"3566_CR6","doi-asserted-by":"publisher","first-page":"122521","DOI":"10.1016\/j.jchromb.2020.122521","volume":"1165","author":"C Tron","year":"2021","unstructured":"Tron C et al (2021) Volumetric absorptive microsampling for the quantification of tacrolimus in capillary blood by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B 1165:122521. https:\/\/doi.org\/10.1016\/j.jchromb.2020.122521","journal-title":"J Chromatogr B"},{"key":"3566_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.chroma.2016.10.075","volume":"1475","author":"C Tron","year":"2016","unstructured":"Tron C et al (2016) A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients. J Chromatogr A 1475:55\u201363. https:\/\/doi.org\/10.1016\/j.chroma.2016.10.075","journal-title":"J Chromatogr A"},{"issue":"3","key":"3566_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Xie S (2010) PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99(3):306\u2013314. https:\/\/doi.org\/10.1016\/j.cmpb.2010.01.007","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"3566_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/FTD.0000000000000503","volume":"40","author":"P Marquet","year":"2018","unstructured":"Marquet P et al (2018) Pharmacokinetic therapeutic drug monitoring of Advagraf in more than 500 adult renal transplant patients, using an expert system online. Ther Drug Monit 40(3):285\u2013291. https:\/\/doi.org\/10.1097\/FTD.0000000000000503","journal-title":"Ther Drug Monit"},{"issue":"3","key":"3566_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/FTD.0b013e318285e779","volume":"35","author":"F Saint-Marcoux","year":"2013","unstructured":"Saint-Marcoux F, Woillard J-B, Jurado C, Marquet P (2013) Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure. Ther Drug Monit 35(3):322\u2013327. https:\/\/doi.org\/10.1097\/FTD.0b013e318285e779","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3566_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/FTD.0000000000000173","volume":"37","author":"K Aouam","year":"2015","unstructured":"Aouam K et al (2015) Development of limited sampling strategies for the estimation of tacrolimus area under the curve in adult kidney transplant recipients according to the posttransplantation time. Ther Drug Monit 37(4):524\u2013530. https:\/\/doi.org\/10.1097\/FTD.0000000000000173","journal-title":"Ther Drug Monit"},{"issue":"13","key":"3566_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4155\/bio-2020-0057","volume":"12","author":"CE Scuderi","year":"2020","unstructured":"Scuderi CE et al (2020) Kidney transplant recipient\u2019s perceptions of blood testing through microsampling and venepuncture. Bioanalysis 12(13):873\u2013881. https:\/\/doi.org\/10.4155\/bio-2020-0057","journal-title":"Bioanalysis"},{"issue":"6","key":"3566_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/FTD.0000000000000923","volume":"43","author":"C Tron","year":"2021","unstructured":"Tron C, Lemaitre F (2021) Perspective on the use of limited sampling strategies to assess drug exposure in the era of microsampling. Ther Drug Monit 43(6):812\u2013813. https:\/\/doi.org\/10.1097\/FTD.0000000000000923","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3566_CR14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","volume":"10","author":"KDS Watt","year":"2010","unstructured":"Watt KDS, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR (2010) Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 10(6):1420\u20131427. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03126.x","journal-title":"Am J Transplant"},{"issue":"3","key":"3566_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2017.07.018","volume":"71","author":"J Trofe-Clark","year":"2018","unstructured":"Trofe-Clark J et al (2018) Results of ASERTAA, a randomized prospective crossover pharmacogenetic study of immediate-release versus extended-release tacrolimus in African American kidney transplant recipients. Am J Kidney Dis 71(3):315\u2013326. https:\/\/doi.org\/10.1053\/j.ajkd.2017.07.018","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"3566_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40262-018-0717-7","volume":"58","author":"C Tron","year":"2019","unstructured":"Tron C, Lemaitre F, Verstuyft C, Petitcollin A, Verdier M-C, Bellissant E (2019) Pharmacogenetics of membrane transporters of tacrolimus in solid organ transplantation. Clin Pharmacokinet 58(5):593\u2013613. https:\/\/doi.org\/10.1007\/s40262-018-0717-7","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3566_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/FTD.0000000000000780","volume":"42","author":"F Lemaitre","year":"2020","unstructured":"Lemaitre F et al (2020) Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel. Ther Drug Monit 42(5):665\u2013670. https:\/\/doi.org\/10.1097\/FTD.0000000000000780","journal-title":"Ther Drug Monit"},{"issue":"3","key":"3566_CR18","doi-asserted-by":"publisher","first-page":"e0230195","DOI":"10.1371\/journal.pone.0230195","volume":"15","author":"C Tron","year":"2021","unstructured":"Tron C et al (2021) Pharmacogenetic\u2014whole blood and intracellular pharmacokinetic\u2014pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients. PLOS ONE 15(3):e0230195. https:\/\/doi.org\/10.1371\/journal.pone.0230195","journal-title":"PLOS ONE"},{"key":"3566_CR19","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jpba.2020.113664","volume":"193","author":"C Tron","year":"2021","unstructured":"Tron C et al (2021) A simple and fast liquid chromatography tandem mass spectrometry method to determine cyclosporine A concentrations in endomyocardial biopsies. J Pharm Biomed Anal 193:113664. https:\/\/doi.org\/10.1016\/j.jpba.2020.113664","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"3566_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","volume":"25","author":"A Capron","year":"2012","unstructured":"Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P (2012) Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int 25(1):41\u201347. https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01365.x","journal-title":"Transpl Int"},{"issue":"5","key":"3566_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/FTD.0000000000000982","volume":"44","author":"S Udomkarnjananun","year":"2022","unstructured":"Udomkarnjananun S et al (2022) Association between the intracellular tacrolimus concentration in CD3+ T lymphocytes and CD14+ monocytes and acute kidney transplant rejection. Ther Drug Monit 44(5):625\u2013632. https:\/\/doi.org\/10.1097\/FTD.0000000000000982","journal-title":"Ther Drug Monit"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03566-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:04:21Z","timestamp":1698735861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03566-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03566-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been authorized by the local ethics committee (authorization number 22\u201388).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients were informed that their data could be used for research purpose including publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The team received a research grant from Sandoz to fund research using microsampling approaches in immunosuppressive drugs monitoring. FL received research grants (paid to institution) from Sandoz, Chiesi and Astellas Pharma and fees to attend meetings from Chiesi.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}